TurtleTree’s precision fermentation lactoferrin becomes first to secure vegan certification

Daniela Castillo Monagas

TurtleTree, a biotech pioneer in sustainable nutrition, has announced the official vegan certification of its animal-free sustainable lactoferrin, LF+, by Vegan Action. This milestone makes TurtleTree the first precision fermentation dairy company globally to obtain vegan certification and the first to receive the Certified Vegan logo since its inception 24 years ago.

While most precision fermentation products do not involve animal products or byproducts, the bioidentical nature of these products and the origins of the genetic codes used in production can raise complex interpretations, particularly when adhering to vegan standards originally designed for plant-based products. TurtleTree’s vegan certification for LF+ demonstrates its commitment to animal welfare and meeting the evolving demands of conscious consumers.

Fengru Lin, CEO and Co-Founder of TurtleTree, said, “With this certification, we are putting words into action and allowing that action to be validated by a third party. We want to build a food system that is sustainable and enables animals to live happier and healthier lives.”

Krissi Vandenberg, Director of Vegan Action, added, “We were thrilled to get TurtleTree’s product Vegan Certified because of the clear benchmark this sets for the rest of the industry. TurtleTree’s dedication to ethical practices and transparency is commendable and will undoubtedly inspire other precision fermentation companies. This certification demonstrates the tangible steps companies can take to validate and communicate their values to customers, underlining a collective commitment to ethical standards.”

With the global vegan food market projected to reach $36 billion by 2031, TurtleTree’s LF+, now the only vegan lactoferrin on the market, is well-positioned to cater to this growing market and support large food and beverage companies seeking innovative, vegan-certified ingredients.

- Advertisement -
Ad imageAd image
Share This Article